NCT06342778View on ClinicalTrials.gov

Pharmacokinetics and Bioequivalence of Doxylamine+Pyridoxine and Diclectin Under Fed Conditions in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

February 27, 2024

Primary Completion Date

May 2, 2024

Study Completion Date

May 2, 2024

Conditions
Nausea
Interventions
DRUG

Doxylamine + Pyridoxine

A single dose of R or T drug in each of 2 periods of the study under fed conditions

DRUG

Diclectin

A single dose of R or T drug in each of 2 periods of the study under fed conditions

Trial Locations (1)

150007

"State budgetary health care institution Yaroslavl region Clinical Hospital № 3", Yaroslavl

All Listed Sponsors
lead

Valenta Pharm JSC

INDUSTRY

NCT06342778 - Pharmacokinetics and Bioequivalence of Doxylamine+Pyridoxine and Diclectin Under Fed Conditions in Healthy Volunteers | Biotech Hunter | Biotech Hunter